Biotech news for Sunday, July 12, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Jul 8, 12:28 PM EDT
Compass Pathways upgraded at Evercore after latest data for psychedelic therapy
CMPS
alexsl Evercore ISI on Wednesday upgraded Compass Pathways ( CMPS ) to Outperform from Inline and raised its price target to $21 from $8 after the U.K.-based biotech updated results from a late-stage trial supporting the long-term efficacy of its psychedelic
Jul 8, 11:57 AM EDT
Sanofi offers to stop disparaging CSL’s flu vaccine after EU probe
SNYGCVRZCMXHF
JHVEPhoto/iStock Editorial via Getty Images The European Commission on Wednesday announced that Sanofi ( SNY ) has agreed to stop disparaging a rival flu vaccine developed by CSL Limited ( CSLLY ) after the French drugmaker faced an EU antitrust probe into its…